[HTML] from 171.66.121.246SE Olofsson, T Tandstad, M Jerkeman… - Journal of Clinical …, 2011 - 171.66.121.246 Purpose From 1995 to 2003, 603 adult patients from Sweden and Norway with metastatic testicular nonseminomatous germ cell tumor (NSGCT) were included prospectively in a population-based protocol with strict guidelines for staging, treatment, and follow-up. Patients with ... Cited by 1 - Related articles - All 5 versions
K Chamie, EA Kurzrock, CP Evans, MS Litwin… - Cancer, 2011 - Wiley Online Library Men on active surveillance for clinical stage I nonseminomatous germ cell tumor (NSGCT) undergo frequent computed tomography imaging to avoid delayed detection of disease. Irradiation from frequent imaging and chemotherapy upon progression may place patients at increased ... Cited by 2 - Related articles - All 2 versions
F Joly, M Paciencia, C Bor… - Journal of Nuclear Medicine, 2011 - Soc Nuclear Med Cisplatin-based chemotherapy has dramatically improved the survival of patients with metastatic testicular cancer, with a cure rate of 80%–90%. However, detection of mature teratoma within residual masses remains a clinical problem in NSGCT patients. Mature teratoma, which is ... Related articles - All 2 versions
T Powles - Hematology/Oncology Clinics of North America, 2011 - Elsevier An increasing proportion of patients with germ cell tumors are presenting with stage I disease. 1 This trend may be partly because of increased awareness among young men. Stage I seminoma occurs more frequently than nonseminoma; however, the unifying factor for ... Related articles - All 3 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
